The real-life impact of vaccination on COVID-19 mortality in Europe and Israel
K Jabłońska, S Aballéa, M Toumi - Public Health, 2021 - Elsevier
Objectives This study aimed at estimating the real-life impact of vaccination on COVID-19
mortality, with adjustment for SARS-CoV-2 variants spread and other factors across Europe …
mortality, with adjustment for SARS-CoV-2 variants spread and other factors across Europe …
Rates and correlates of employment in people with schizophrenia in the UK, France and Germany
…, JM Azorin, R Kilian, K Hansen, M Toumi - The British Journal of …, 2007 - cambridge.org
BackgroundLittle is known about international variations in employment rates among
people with schizophrenia or about the factors associated with employment in this disorder.AimsTo …
people with schizophrenia or about the factors associated with employment in this disorder.AimsTo …
[HTML][HTML] Managed entry agreements: policy analysis from the European perspective
M Dabbous, L Chachoua, A Caban, M Toumi - Value in Health, 2020 - Elsevier
Background Mounting pressures on the healthcare system, such as budget constraints and
new, costly health technologies reaching the market, have pushed payers and manufacturers …
new, costly health technologies reaching the market, have pushed payers and manufacturers …
[PDF][PDF] External reference pricing of medicinal products: simulation-based considerations for cross-country coordination
M Toumi, C Remuzat, AL Vataire… - Final Report. European …, 2014 - health.ec.europa.eu
European Union (EU) Member States (MS) are free to develop their national and regional
pharmaceutical pricing and reimbursement policies, as long as they comply with the …
pharmaceutical pricing and reimbursement policies, as long as they comply with the …
Relapse in schizophrenia: costs, clinical outcomes and quality of life
S Almond, M Knapp, C Francois, M Toumi… - The British Journal of …, 2004 - cambridge.org
BackgroundRelapse is one of the most costly aspects of schizophrenia.AimsTo compare
costs, clinical outcomes and quality of life for patients who experienced relapse in …
costs, clinical outcomes and quality of life for patients who experienced relapse in …
Burden on caregivers of people with schizophrenia: comparison between Germany and Britain
BackgroundBurden on the relatives of patients with schizophrenia may be influenced not
only by patient and caregiver characteristics, but also by differences in mental health service …
only by patient and caregiver characteristics, but also by differences in mental health service …
Gene therapies development: slow progress and promising prospect
E Hanna, C Rémuzat, P Auquier, M Toumi - Journal of market access & …, 2017 - mdpi.com
Background: In 1989, the concept of human gene therapies has emerged with the first
approved human gene therapy trial of Rosenberg et al. Gene therapies are considered as …
approved human gene therapy trial of Rosenberg et al. Gene therapies are considered as …
Advanced therapy medicinal products: current and future perspectives
E Hanna, C Rémuzat, P Auquier, M Toumi - Journal of market access & …, 2016 - mdpi.com
Background: Advanced therapy medicinal products (ATMPs) are innovative therapies that
encompass gene therapy, somatic cell therapy, and tissue-engineered products. These …
encompass gene therapy, somatic cell therapy, and tissue-engineered products. These …
[HTML][HTML] Subjective health status and health-related quality of life among women with recurrent vulvovaginal candidosis (RVVC) in Europe and the USA
…, A Khemiri, JP Dietz, J Sobel, M Toumi - Health and quality of life …, 2013 - Springer
Background Recurrent vulvovaginal candidosis (RVVC) is a chronic condition causing
discomfort and pain. Health status and health-related quality of life (HRQoL) in RVVC were never …
discomfort and pain. Health status and health-related quality of life (HRQoL) in RVVC were never …
[HTML][HTML] Quality of life is predictive of relapse in schizophrenia
Background The objective of this study was to evaluate whether quality of life (QoL), as
measured by the SF36 and the Quality of Life Interview (QoLI), is predictive of relapse for patients …
measured by the SF36 and the Quality of Life Interview (QoLI), is predictive of relapse for patients …